We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Prokarium Announces MHRA Acceptance To Run Phase I Trial of Enteric Fever Vaccine

Product News   Nov 26, 2019

 
Prokarium Announces MHRA Acceptance To Run Phase I Trial of Enteric Fever Vaccine
FURTHER INFORMATION
 
 
 

Related Product News

Inceptua and Bendalis Enter Into Oncology Medicine Supply Agreement for Clinical Trials

Product News

The global pharmaceutical company and service partner Inceptua and Bendalis have announced the signing of an exclusive clinical trial supply agreement for oncology generics.

READ MORE

Advancing the Possibility of Personalized Neoantigen Cancer Vaccines

Product News

NEC and VAXIMM, a biotech company focused on developing oral T-cell immunotherapies, have announced a clinical trial collaboration to develop novel personalized neoantigen cancer vaccines.

READ MORE

Tumor Regression with New Antibody-Drug Conjugate

Product News

Iksuda Therapeutics (Iksuda), a developer of next generation Antibody Drug Conjugates (ADCs), has announced the first data on its lead ADC, IKS01.

READ MORE

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE